1.Comparative study of transcatheter intervention of VSD with large sack with thin-waist-big-side occluder and symmetrical occluder
Chinese Journal of Interventional Cardiology 2003;0(06):-
0.05).Conclusions Transcatheter intervention of VSD with large sack both thin-waist-big-side occluder or symmetrical occluder showed satisfactory result.Attention should be paid in the indications of these 2 types of occluders.
2.Novel strategies for promoting tumor penetration of anticancer nanomedicines
Jing HUANG ; Jun-na ZOU ; Huan-huan REN ; Shan WANG
Acta Pharmaceutica Sinica 2022;57(6):1758-1770
There is a broad and urgent need for the clinical application of anticancer nanomedicine in tumor therapy, but the complex biological barrier in solid tumors has always been the main obstacle to infiltrating nanomedicine into the tumor. The traditional design of nanomedicine based on enhanced permeability and retention (EPR) effect still has some limitations in tumor permeability, it is urgent to find other design theories. Therefore, this review summarizes two novel strategies, active transcytosis and immune cell-mediated tumor penetration, for promoting tumor penetration of anticancer nanomedicine.
3.Transthoracic echocardiographic guidance for closure of atrial septal defects with amplatzer occlusion device
Huan LI ; Yushun ZHANG ; Jun ZHANG
Chinese Journal of Interventional Cardiology 1993;0(02):-
Objective To evaluate transthoracic echocardiographic guidance for closure of atrial septal defects with Amplatzer occlusion device in the adults Methods Thirty patients with atrial septal defects were occluded by use of Amplatzer septal occluder The mean age was (32 3?14 7) years (ranging from 13-65 years) Transthoracic echocardiography was undertaken for guidance for closure before and in the procedure of intervention Transthoracic echocardiography was done immediately, one month and three month respectively after intervention to evaluate the treatment efficiency Results Twenty four patients were treated successfully directly by guidance of transthoracic echocardiography during the period of closure, the total effectiveness was 80%. Five patients needed to have transesophageal echocardiography before closure to select indication and another one patient was treated successfully by adding transesophageal echocardiography for guidance in the procedure There was no significant complication that occurred during the procedures, and there was no emergency surgical case Trivial to small residual shunts were found in 2 cases (6 7%) immediately after the procedure No residual shunts were found in the one month follow up, and all patients had no displacement and recanalization in the one month follow up Conclusion Transthoracic echocardiography can guide most of atrial septal defect patients for closure of atrial septal defects with the Amplatzer occlusion device
4.Clinical Features of Acute Leukemia with Positive Mixed Lineage Leukemia Fusion Gene in Children
Journal of Applied Clinical Pediatrics 2006;0(20):-
Objective To analyze the clinical features of acute leukemia(AL) with positive mixed lineage leukemia(MLL)fusion gene in children,and explore their treatment protocols,prognosis factors,and so on.Methods Clinical features,treatment protocols,and prognosis factors were studied retrospectively among 51 AL patients with MLL fusion gene.MLL fusion gene was detected by morphology immunology,cytogenetics,molecul arbiology and reverse transcrption polymerase chain reaction(RT-PCR).Results Fifty-one AL patients with MLL fusion gene positive,included 37 cases of acute lymphoblastic leukemia(ALL) and 14 cases of acute myelocytic leukemia(AML).Forty-two patients exhibited abnormal clonal chromosome 11.MLL fusion gene rearrangements and MLL fusion gene partial tandem duplication were found among 36 cases and 15 cases,respectively.Thirty-two cases who received regular chemotherapy were followed up.Twenty-four cases including 19 cases of ALL and 5 cases of AML had achieved complete remission(CR).Six cases including 5 cases of ALL and 1 cases of AML had achieved more than 2 years CR.Sixteen cases were alive update including 12 cases of ALL and 4 cases of AML.Ten cases of positive MLL fusion gene were turning negative.Up to now,6 cases relapsed and 6 cases were dead.Conclusions The incidence of AL children with positive MLL fusion gene is low.It has some features,such as,high replapse rate and poor prognosis.A few patients sensitive to chemotherapies can achieve CR.They live with constant negative MLL fusion gene.
5.Clinical analysis of 201 cases of childhood acute myelocytic leukemia.
Jun-jie FAN ; Yi-huan CHAI ; Hai-long HE
Chinese Journal of Pediatrics 2007;45(11):873-874
Adolescent
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Leukemia, Myeloid
;
pathology
;
physiopathology
;
Male
6.Mechanism of "treating heart and brain with same methods" based on data science.
Di CHEN ; Shi-huan TANG ; Peng LU ; Hong-jun YANG
China Journal of Chinese Materia Medica 2015;40(21):4288-4296
The traditional Chinese medicine (TCM) theory of "treating heart and brain diseases with same methods (Nao Xin Tong Zhi: NXTZ)" has great significance to the treatment of cardiovascular and cerebrovascular diseases. It has been proven effective by a great deal of clinical researches. However, the underlying mechanism for this theory is still unclear. To provide insights into the potential mechanism of "NXTZ", this study attempts to deeply investigate the mechanism from two representative cardiovascular and cerebrovascular diseases, coronary heart disease (CHD) and cerebral apoplexy. First, various data resources were integrated to obtain different types of biomedical entities including drugs, targets, pathways and diseases. Then, three different approaches including text mining, biological network and enrichment analysis were utilized to recognize the potential common features between CHD and cerebral apoplexy, and the corresponding functions of drugs which could treat both diseases, thus unveiling the mechanism of NXTZ.
Brain
;
drug effects
;
Coronary Artery Disease
;
drug therapy
;
genetics
;
metabolism
;
Databases, Bibliographic
;
Drugs, Chinese Herbal
;
therapeutic use
;
Heart
;
drug effects
;
Humans
;
Stroke
;
drug therapy
;
genetics
;
metabolism
9.Changes of serum fibroblast growth factor 23 in patients with end stage renal disease and its clinical significance
Junli ZHANG ; Hongdi HUAN ; Jinghong ZHANG ; Jun YANG ; Beili LU
Academic Journal of Second Military Medical University 2000;0(10):-
Objective:To observe the serum level of fibroblast growth factor-23(FGF-23) in patients with end stage renal disease (ESRD) and study its association with phosphorus and vitamin D metabolism.Methods: Serum FGF-23 level was determined by enzyme-linked immunosorbent assay (ELISA) in ESRD patients undergoing haemodialysis (HD, n=50) and peritoneal dialysis (PD, n=24) and in twenty healthy controls (control group,n=20).Serum level of 1,25-(OH) 2VitD was measured by enzyme immunoassay(EIA).Serum intact parathyroid hormone (PTH), creatinine, and calcium and phosphorus were also measured.Results: Serum FGF-23 was obviously higher in HD group([88.51?35.01] ng/L vs [11.76?3.63] ng/L)and PD group([87.85?33.65] ng/L vs [11.76?3.63] ng/L)than in control group. Moreover, the serum level of 1,25-(OH)2VitD was lower in HD and PD groups than in control group ([19.82?4.99] pmol/L vs [48.37?3.47] pmol/L; [24.31?7.11] pmol/L vs [48.37?3.47] pmol/L ), and the level of 1,25-(OH)2VitD was much lower in HD group than in PD group. Pearson relativity analysis showed that serum FGF-23 level was positively correlated with serum creatinine, phosphorus, intact PTH and duration of dialysis(P